生体吸収性ポリマーの市場：製品タイプ、形態、製造プロセス、材料タイプ、用途、エンドユーザー別-2025～2030年の世界予測

生体吸収性ポリマー市場は、2024年には9億9,848万米ドルとなり、2025年には11億103万米ドルに成長し、CAGRは10.51%、2030年には18億1,930万米ドルに達すると予測されています。

生体吸収性ポリマーは、生分解性と機能性のユニークな組み合わせを提供し、バイオメディカルと製造セグメントにおける最先端のフロンティアです。近年、医療や先端製造業において、持続可能で患者に優しいソリューションへの需要が高まるにつれ、これらの材料は重要性を増しています。生体吸収性ポリマー固有の特性により、体内で安全に分解されるため、外科手術による除去の必要がなく、長期的な合併症の発生を抑えることができます。この技術革新は、医療処置に革命をもたらすだけでなく、ドラッグデリバリーシステム、組織工学、医療用インプラントの新たな可能性にも道を開いています。

生体吸収性ポリマーの進化は、材料科学の急速な進歩、研究開発投資の増加、患者中心の医療ソリューションの重視の高まりによって加速されてきました。また、製造プロセスも高度化し、これらの材料の性能、信頼性、安全性が厳しい規制基準を満たすようになっています。薬剤放出制御、心血管や整形外科のインプラント技術、再生医療などのセグメントでの新たな応用により、この市場は臨床転帰と生産効率の両方に変革的な影響を確立する態勢を整えています。

本エグゼクティブサマリーでは、製品イノベーション、セグメンテーション研究、地域別成長動向などの深堀り分析に裏付けされた、現在の市場力学の包括的な概要を発表します。生体吸収性ポリマーの情勢が進化し続ける中、主要促進要因・課題・機会を理解することは、このダイナミックな市場で競合を求める利害関係者にとって不可欠となります。

生体吸収性ポリマー市場の変革

生体吸収性ポリマーの市場情勢は、技術革新、規制状況の進化、医療需要の変化などにより、大きく変化しています。最近のポリマー化学と加工技術の飛躍的進歩により、生体吸収性ポリマーの用途は拡大し、最新の医療産業用途の数々に対して十分な汎用性を持つようになりました。従来の材料は現在、生体吸収性のオプションによって補われたり、置き換わったりしており、特に長期間の材料の存在がリスクとなりうるセグメントでは、より安全で効率的な結果を保証しています。

製造プロセスの進歩により、生産が合理化され、コストが削減され、望ましい分解プロファイルを持つポリマーの高精度な製造が可能になりました。利害関係者は現在、従来の抽出・加工技術から、効率性と生体適合性を重視した、よりサステイナブル方法への転換を目の当たりにしています。同時に、エコフレンドリー製品を求める世界の高まりは、材料の選択と開発のあり方に影響を与え、さまざまなセグメントでの生体吸収性ポリマーの統合をさらに加速させています。

市場関係者は、製品性能を向上させるために研究開発に多額の投資を行い、革新的なソリューションを商業化するために戦略的パートナーシップを結ぶことで、こうした変化を活用しています。この変化は規制状況にも表れており、安全性ガイドラインの強化により、生体吸収性製品が患者ケアのための最高基準を満たすことが保証されています。科学的・経済的な要請の両方によって引き起こされるこのような競合環境は、適応の成功が大きな報酬につながる可能性のある市場競争の舞台となっています。

市場分析のための主要セグメンテーション洞察

生体吸収性ポリマー市場は、様々なパラメータに基づいて複雑にセグメント化されており、このセグメントのビジネス機会を多角的に捉えています。製品別に詳細に評価すると、繊維、フィルム、マイクロ粒子、ナノ材料などの革新的製品が開発されており、それぞれが特定の用途に特化した特性を提供していることがわかる。形態による分析では、これらの材料が液体、粉末、固体にさらに分類され、多様な産業と医療要件を満たすために必要な汎用性が強調されています。

さらに、ブロー成形、押出成形、射出成形などの製造プロセスを注意深く検討することで、これらのポリマーの性能を最適化するために、製造技術がどのように調整されているかが見えてくる。製造方法によって、最終製品は、高精度の医療用インプラントであれ、薬剤放出制御機構であれ、その用途にとって重要なさまざまな特性を示す可能性があります。

材料タイプは、ポリアンヒドリド、ポリカプロラクトン（PCL）、ポリグリコール酸（PGA）、ポリヒドロキシアルカノエート（PHA）、ポリ乳酸（PLA）に分類され、もう一つの重要なセグメンテーションの角度となります。これらの材料はそれぞれ、分解性と機械的強度の点でユニークな特性を示し、医療機器製造や再生医療における様々な特殊作業への適性に影響を与えています。

用途を検討すると、生体吸収性ポリマーがドラッグデリバリーシステム、医療用インプラント、組織工学、創傷治癒装置において極めて重要であることが明らかになります。例えば、ドラッグデリバリーシステムは放出制御製剤や標的特異的ビヒクルとして最適化され、医療用インプラントは心血管用ステントや整形外科用インプラントに特化した機能で設計されています。同様に、組織工学は骨格設計と幹細胞骨格技術から恩恵を受け、創傷治癒装置は患者の回復を促進するために接着ソリューションと包帯材料を組み込んでいます。エンドユーザー別に見ると、市場はバイオテクノロジー企業、病院クリニック、製薬会社、研究機関などに広がっています。この市場セグメンテーションの枠組みは、的を絞った戦略開拓を可能にし、生体吸収性ポリマー市場の多様な用途と技術的な複雑さを反映しています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 外科手術における生体吸収性縫合糸とインプラントの使用増加
    • ポリマードラッグデリバリーと3Dプリンティング医療インプラントにおける生体吸収性ポリマーの採用拡大
    • いくつかの外科手術に対する有利な償還施策
  • 抑制要因
    • 生体吸収性ポリマーの生産に必要な原料の供給が限られている
  • 機会
    • 革新的な整形外科用インプラントと外科用機器の継続的な進歩
    • バイオベースの生体吸収性ポリマーの研究開発に対する政府の支援的取り組み
  • 課題
    • 生体吸収性ポリマーの技術的な制限とパフォーマンスの問題
• 市場セグメンテーション分析
  • 製品：医療用縫合糸と組織工学における生体吸収性ポリマー繊維の好まれな傾向
  • 用途：組織工学における生体吸収性ポリマーの応用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 生体吸収性ポリマー市場：製品別

• イントロダクション
• 繊維
• フィルム
• 微粒子
• ナノマテリアル

第7章 生体吸収性ポリマー市場：形態別

• イントロダクション
• 液体
• 粉末
• 固体

第8章 生体吸収性ポリマー市場：製造プロセス別

• イントロダクション
• ブロー成形
• 押出
• 射出成形

第9章 生体吸収性ポリマー市場：材料タイプ別

• イントロダクション
• ポリ無水物
• ポリカプロラクトン（PCL）
• ポリグリコール酸（PGA）
• ポリヒドロキシアルカン酸（PHA）
• ポリ乳酸（PLA）

第10章 生体吸収性ポリマー市場：用途別

• イントロダクション
• ドラッグデリバリーシステム
  • 制御放出製剤
  • 対象固有の車両
• 医療インプラント
  • 心血管ステント
  • 整形外科インプラント
• 組織工学
  • 骨格設計
  • 幹細胞の骨格
• 創傷治癒デバイス
  • 接着剤ソリューション
  • 包帯材

第11章 生体吸収性ポリマー市場：エンドユーザー別

• イントロダクション
• バイオテクノロジー企業
• 病院とクリニック
• 製薬会社
• 研究機関

第12章 南北アメリカの生体吸収性ポリマーの市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋の生体吸収性ポリマーの市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの生体吸収性ポリマーの市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析、2024年
• FPNVポジショニングマトリックス、2024年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3D BIoTek LLC
• Acuro Organics Limited
• Advanced Polymer Materials Inc.
• Anhui Jumei Biological Technology Co., Ltd.
• Ashland Inc.
• Avantium N.V.
• BMG Incorporated
• CD Bioparticles
• Corbion NV
• Evonik Industries AG
• Foster Corporation
• Futerro Group
• Galatea Surgical, Inc.
• Huizhou Foryou Medical Devices Co., Ltd.
• Koninklijke DSM N.V.
• MAST Biosurgery
• Merck KGaA
• Mitsui & Co., Ltd.
• Nanosoft Polymers
• Nomisma Healthcare Pvt. Ltd.
• Otto Chemie Pvt. Ltd.
• Poly-Med Incorporated
• PolyNovo Limited
• Polysciences, Inc.
• Putnam Plastics
• REVA Medical, LLC
• Rivika Bio Industries Pvt. Ltd.
• SEQENS SAS
• Solanyl Biopolymers Inc.
• SpecialChem S.A.
• Stahl Holdings B.V.
• Torise Biomaterials Co.,Ltd.
• UBQ Materials Ltd.
• Vibha Ecopac Pvt Ltd.
• Zeus Industrial Products, Inc.

LIST OF FIGURES

• FIGURE 1. BIORESORBABLE POLYMERS MARKET MULTI-CURRENCY
• FIGURE 2. BIORESORBABLE POLYMERS MARKET MULTI-LANGUAGE
• FIGURE 3. BIORESORBABLE POLYMERS MARKET RESEARCH PROCESS
• FIGURE 4. BIORESORBABLE POLYMERS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 19. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 23. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 28. BIORESORBABLE POLYMERS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 29. BIORESORBABLE POLYMERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. BIORESORBABLE POLYMERS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIORESORBABLE POLYMERS MARKET DYNAMICS
• TABLE 7. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 67. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 68. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 75. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 76. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 77. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 78. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 81. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 82. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 83. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 85. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 86. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 87. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 88. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 91. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 92. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 93. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 95. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 96. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 97. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 98. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 101. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 102. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 103. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 105. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 106. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 107. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 108. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 110. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 112. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 114. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 116. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 117. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 118. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 121. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 123. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 124. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 125. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 127. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 128. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 129. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 130. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 133. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 134. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 135. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 137. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 138. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 139. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 140. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 143. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 144. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 145. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 147. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 148. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 149. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 150. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 153. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 154. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 155. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 157. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 158. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 159. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 163. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 164. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 165. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 167. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 168. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 169. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 170. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 173. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 174. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 175. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 177. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 178. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 179. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 180. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 183. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 184. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 185. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 187. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 188. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 189. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 193. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 194. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 195. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 197. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 198. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 199. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 200. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 213. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 214. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 215. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 217. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 218. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 219. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 220. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 223. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 224. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 225. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 227. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 228. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 229. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 230. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 233. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 234. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 235. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 237. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 238. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 239. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 240. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 242. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 243. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 244. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 245. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 250. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 252. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 253. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 254. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 255. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 256. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 257. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 258. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 259. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 260. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 261. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 262. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 263. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 264. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 265. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 266. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 267. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 268. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 269. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 270. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 271. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 272. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 273. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 274. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 275. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 276. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 277. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 278. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 279. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 280. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 281. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 282. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 283. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 284. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 285. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 286. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 287. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 288. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 289. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 290. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 291. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 292. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 293. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 294. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 295. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 296. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 297. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 298. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 299. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 300. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 301. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 302. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 303. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 304. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 305. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 306. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 307. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 308. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 309. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 310. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 311. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 312. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 313. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 314. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 315. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 316. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 317. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 318. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 319. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 320. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
• TABLE 321. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 322. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 323. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 324. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
• TABLE 325. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 326. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 327. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 328. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
• TABLE 329. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)

TABLE 33

The Bioresorbable Polymers Market was valued at USD 998.48 million in 2024 and is projected to grow to USD 1,101.03 million in 2025, with a CAGR of 10.51%, reaching USD 1,819.30 million by 2030.

Bioresorbable polymers represent a cutting-edge frontier in the biomedical and manufacturing sectors, offering a unique combination of biodegradability and functionality. In recent years, these materials have gained significant importance as the demand for sustainable and patient-friendly solutions in healthcare and advanced manufacturing has increased. The inherent properties of bioresorbable polymers allow them to safely degrade within the body, eliminating the need for surgical removal and reducing long-term complications. This innovation is not only revolutionizing medical procedures but also paving the way for new possibilities in drug delivery systems, tissue engineering, and medical implants.

The evolution of bioresorbable polymers has been accelerated by rapid advancements in material science, increased R&D investments, and a growing emphasis on patient-centric healthcare solutions. Manufacturing processes have also become more sophisticated, ensuring that the performance, reliability, and safety of these materials meet stringent regulatory standards. With emerging applications in sectors such as controlled drug release, cardiovascular and orthopedic implant technology, and regenerative medicine, this market is poised to establish a transformative impact on both clinical outcomes and production efficiencies.

This executive summary presents a comprehensive overview of the current market dynamics, supported by deep-dive analyses into product innovations, segmentation studies, and regional growth trends. As the landscape of bioresorbable polymers continues to evolve, understanding the key drivers, challenges, and opportunities becomes essential for stakeholders seeking a competitive edge in this dynamic market.

Transformative Shifts in the Market Landscape

The landscape of the bioresorbable polymers market is undergoing transformative shifts driven by technological innovations, evolving regulatory frameworks, and changing healthcare demands. Recent breakthroughs in polymer chemistry and processing techniques have expanded the applications of these materials, making them versatile enough for a host of modern medical and industrial applications. Traditional materials are now being supplemented or replaced by bioresorbable options, ensuring safer and more efficient outcomes, particularly in areas where long-term material presence can pose a risk.

Advancements in manufacturing processes have streamlined production, reduced costs, and enabled higher precision in fabricating polymers with desirable degradation profiles. Stakeholders are now witnessing a shift from conventional extraction and processing techniques to more sustainable methods that emphasize efficiency and biocompatibility. At the same time, the global push for environmentally conscious products is influencing how materials are selected and developed, further accelerating the integration of bioresorbable polymers in a variety of sectors.

Market players are leveraging these changes by investing heavily in R&D to refine product performance and by forming strategic partnerships to commercialize innovative solutions. The transformation is also evident in the regulatory landscape, where enhanced safety guidelines ensure that bioresorbable products meet the highest standards for patient care. This environment of change, driven by both scientific and economic imperatives, sets the stage for a competitive market where successful adaptation can lead to significant rewards.

Key Segmentation Insights for Market Analysis

The bioresorbable polymers market is intricately segmented based on various parameters that together frame a multi-dimensional view of the sector's opportunities. A deep evaluation by product reveals that innovations are being developed across fibers, films, micro-particles, and nanomaterials, each offering distinctive properties for specific applications. Analysis based on form further categorizes these materials into liquid, powder, and solid, highlighting the versatility needed to meet diverse industrial and healthcare requirements.

In addition, a careful review of manufacturing processes such as blow molding, extrusion, and injection molding sheds light on how production techniques are tailored to optimize the performance of these polymers. Depending on the manufacturing method, the end product may exhibit varying characteristics that are crucial for its application, whether that be in a high-precision medical implant or a controlled drug release mechanism.

Material type serves as another important segmentation angle, with classifications into polyanhydrides, polycaprolactone (PCL), polyglycolic acid (PGA), polyhydroxyalkanoate (PHA), and polylactic acid (PLA). Each of these materials presents a unique set of properties in terms of degradability and mechanical strength, influencing their suitability for a range of specialized tasks in medical device manufacturing and regenerative medicine.

When examining applications, it becomes clear that bioresorbable polymers are pivotal in drug delivery systems, medical implants, tissue engineering, and wound healing devices. A closer look reveals further granularity; for instance, drug delivery systems are optimized as controlled release formulations and target-specific vehicles, while medical implants are designed with specialized features for cardiovascular stents and orthopedic implants. Similarly, tissue engineering benefits from scaffold designs and stem cell scaffolding techniques, and wound healing devices incorporate adhesive solutions and bandaging materials to enhance patient recovery. Exploring the end-user dimension, the market stretches across biotechnology companies, hospitals and clinics, pharmaceutical companies, and research institutes. This segmentation framework allows for targeted strategy development and reflects the diverse range of applications and technological intricacies within the bioresorbable polymers market.

Based on Product, market is studied across Fibers, Films, Micro-Particles, and Nanomaterials.

Based on Form, market is studied across Liquid, Powder, and Solid.

Based on Manufacturing Process, market is studied across Blow Molding, Extrusion, and Injection Molding.

Based on Material Type, market is studied across Polyanhydrides, Polycaprolactone (PCL), Polyglycolic Acid (PGA), Polyhydroxyalkanoate (PHA), and Polylactic Acid (PLA).

Based on Application, market is studied across Drug Delivery Systems, Medical Implants, Tissue Engineering, and Wound Healing Devices. The Drug Delivery Systems is further studied across Controlled Release Formulations and Target-Specific Vehicles. The Medical Implants is further studied across Cardiovascular Stents and Orthopedic Implants. The Tissue Engineering is further studied across Scaffold Designs and Stem Cell Scaffolding. The Wound Healing Devices is further studied across Adhesive Solutions and Bandaging Materials.

Based on End-User, market is studied across Biotechnology Companies, Hospitals and Clinics, Pharmaceutical Companies, and Research Institutes.

Key Regional Insights and Growth Opportunities

The global market for bioresorbable polymers can be characterized by its regional diversity, with significant growth observed in the Americas, Europe, Middle East & Africa, and the Asia-Pacific regions. In the Americas, advanced healthcare systems and robust research infrastructure foster an environment conducive to the rapid adoption of innovative bioresorbable solutions. This region benefits from established manufacturing capabilities and strong governmental support, all of which accelerate market penetration and infrastructural development.

Europe, Middle East & Africa offer a unique blend of stringent regulatory demands and meticulous quality controls that drive innovation in bioresorbable materials. The region is marked by an increasing focus on sustainability, which aligns with the environmentally friendly nature of these polymers, spurring both industrial and clinical research initiatives.

Asia-Pacific stands out as a dynamic market driven by fast-paced technological advancements and an expanding consumer base. Strong government initiatives supporting research and development, combined with rapidly growing healthcare and biotechnology sectors, have positioned the region as a hub for both innovation and manufacturing. These regional advantages are instrumental in shaping the future trajectory of the market, as industry players tailor their strategies to cater to the specific needs and regulatory frameworks of each area.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Catalyzing Market Innovation

The bioresorbable polymers market is marked by the strategic maneuvers of several leading companies that are driving innovation and setting benchmarks for performance. Industry pioneers such as 3D Biotek LLC and Acuro Organics Limited have been instrumental in advancing the product portfolio by investing in state-of-the-art production techniques. Global players like Advanced Polymer Materials Inc. and Anhui Jumei Biological Technology Co., Ltd. continue to push the boundaries in development, taking a holistic approach to integrate research with market needs.

Established entities like Ashland Inc. and Avantium N.V. have demonstrated robust capabilities in both capturing and expanding market share, while BMG Incorporated and CD Bioparticles focus on niche applications that address specific clinical challenges. Companies such as Corbion NV and Evonik Industries AG are well-known for their commitment to quality and innovation, consistently refining the properties of bioresorbable polymers to meet more critical demand spikes. This drive for excellence is further bolstered by the contributions of Foster Corporation, Futerro Group, and Galatea Surgical, Inc., whose strategies are oriented towards combining creative engineering with regulatory compliance.

Huizhou Foryou Medical Devices Co., Ltd., Koninklijke DSM N.V., and MAST Biosurgery provide comprehensive solutions that have resulted in increased efficacy and greater patient safety. Meanwhile, Merck KGaA, Mitsui & Co., Ltd., and Nanosoft Polymers continue to strengthen their market positions by leveraging decades of expertise to foster innovation and productivity. Notably, Nomisma Healthcare Pvt. Ltd., Otto Chemie Pvt. Ltd., and Poly-Med Incorporated maintain a steadfast focus on application-specific solutions, underpinning their offerings with thorough research and robust production methods. With a dynamic mix of established and emerging players such as PolyNovo Limited, Polysciences, Inc., Putnam Plastics, and REVA Medical, LLC, the landscape remains highly competitive and ripe with opportunities for further innovation. Rivika Bio Industries Pvt. Ltd., SEQENS SAS, Solanyl Biopolymers Inc., SpecialChem S.A., Stahl Holdings B.V., Torise Biomaterials Co.,Ltd., UBQ Materials Ltd., Vibha Ecopac Pvt Ltd., and Zeus Industrial Products, Inc. collectively illustrate the scale and diversity of the market, each leveraging their unique strengths to address evolving customer needs and industry trends.

The report delves into recent significant developments in the Bioresorbable Polymers Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek LLC, Acuro Organics Limited, Advanced Polymer Materials Inc., Anhui Jumei Biological Technology Co., Ltd., Ashland Inc., Avantium N.V., BMG Incorporated, CD Bioparticles, Corbion NV, Evonik Industries AG, Foster Corporation, Futerro Group, Galatea Surgical, Inc., Huizhou Foryou Medical Devices Co., Ltd., Koninklijke DSM N.V., MAST Biosurgery, Merck KGaA, Mitsui & Co., Ltd., Nanosoft Polymers, Nomisma Healthcare Pvt. Ltd., Otto Chemie Pvt. Ltd., Poly-Med Incorporated, PolyNovo Limited, Polysciences, Inc., Putnam Plastics, REVA Medical, LLC, Rivika Bio Industries Pvt. Ltd., SEQENS SAS, Solanyl Biopolymers Inc., SpecialChem S.A., Stahl Holdings B.V., Torise Biomaterials Co.,Ltd., UBQ Materials Ltd., Vibha Ecopac Pvt Ltd., and Zeus Industrial Products, Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to closely monitor emerging trends and invest in R&D initiatives that focus on enhancing product performance and manufacturing efficiency. Strategic collaborations and partnerships across sectors are essential to tap into diverse applications and to respond swiftly to ever-changing regulatory environments. Emphasizing customer-centric design and robust quality assurance practices will further strengthen market positioning in this competitive landscape. Leaders should also prioritize sustainability and compliance, ensuring that each step in the development cycle aligns with best practices while maximizing patient safety and environmental impacts.

Conclusion and Future Outlook

In conclusion, the market for bioresorbable polymers is at an exciting inflection point, characterized by rapid technological advancement and expanding applications across diverse sectors. The increasing adoption of innovative manufacturing processes, coupled with targeted segmentation strategies, is paving the way for sustainable and clinically effective solutions. As industry leaders continue to leverage new research and adapt to evolving regulatory frameworks, the future of bioresorbable polymers appears promising, with clear pathways for growth and innovation. Continuous improvements in material science and production methodology are expected to further bolster the market's potential, making this a fertile ground for investment and strategic expansion.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing usage of bioresorbable sutures and implants in surgical procedures
    • 5.1.1.2. Growing adoption of bioresorbable polymers for polymeric drug delivery and 3D printed medical implants
    • 5.1.1.3. Favorable reimbursement policies for several surgical procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of raw materials for the production of bioresorbable polymers
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in innovative orthopedic implants and surgical devices
    • 5.1.3.2. Supportive government initiatives in research and development of bio-based bioresorbable polymer
  • 5.1.4. Challenges
    • 5.1.4.1. Technical limitations and performance issues in bioresorbable polymers
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing preference for bioresorbable polymer fibers in medical sutures and tissue engineering
  • 5.2.2. Application: Expanding application of bioresorbable polymers in tissue engineering
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bioresorbable Polymers Market, by Product

• 6.1. Introduction
• 6.2. Fibers
• 6.3. Films
• 6.4. Micro-Particles
• 6.5. Nanomaterials

7. Bioresorbable Polymers Market, by Form

• 7.1. Introduction
• 7.2. Liquid
• 7.3. Powder
• 7.4. Solid

8. Bioresorbable Polymers Market, by Manufacturing Process

• 8.1. Introduction
• 8.2. Blow Molding
• 8.3. Extrusion
• 8.4. Injection Molding

9. Bioresorbable Polymers Market, by Material Type

• 9.1. Introduction
• 9.2. Polyanhydrides
• 9.3. Polycaprolactone (PCL)
• 9.4. Polyglycolic Acid (PGA)
• 9.5. Polyhydroxyalkanoate (PHA)
• 9.6. Polylactic Acid (PLA)

10. Bioresorbable Polymers Market, by Application

• 10.1. Introduction
• 10.2. Drug Delivery Systems
  • 10.2.1. Controlled Release Formulations
  • 10.2.2. Target-Specific Vehicles
• 10.3. Medical Implants
  • 10.3.1. Cardiovascular Stents
  • 10.3.2. Orthopedic Implants
• 10.4. Tissue Engineering
  • 10.4.1. Scaffold Designs
  • 10.4.2. Stem Cell Scaffolding
• 10.5. Wound Healing Devices
  • 10.5.1. Adhesive Solutions
  • 10.5.2. Bandaging Materials

11. Bioresorbable Polymers Market, by End-User

• 11.1. Introduction
• 11.2. Biotechnology Companies
• 11.3. Hospitals and Clinics
• 11.4. Pharmaceutical Companies
• 11.5. Research Institutes

12. Americas Bioresorbable Polymers Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Bioresorbable Polymers Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Bioresorbable Polymers Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Sonavex Inc. raises USD 15 million in Series A-2 funding
  • 15.3.2. The POLYMEER initiative, funded with EUR 4.9 million by the circular bio-based Europe joint undertaking HORIZON program
  • 15.3.3. Ashland completes its second expansion of the Viatel bioresorbable polymers manufacturing and R&D lab
  • 15.3.4. Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
  • 15.3.5. Evonik backs Allay's development of pain therapy implants
  • 15.3.6. Collagen matrix acquires polyganics
  • 15.3.7. Technip energies acquires Biosuccinium technology from DSM for bio-sourced and fully biodegradable polymers production
  • 15.3.8. Ashland expands bioresorbable development site in Ireland
  • 15.3.9. Biotech startup String Bio raises $20M in funding from Woodside Energy Group, others
  • 15.3.10. Amerigo scientific launches polycaprolactone for bioprinting
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3D Biotek LLC
• 2. Acuro Organics Limited
• 3. Advanced Polymer Materials Inc.
• 4. Anhui Jumei Biological Technology Co., Ltd.
• 5. Ashland Inc.
• 6. Avantium N.V.
• 7. BMG Incorporated
• 8. CD Bioparticles
• 9. Corbion NV
• 10. Evonik Industries AG
• 11. Foster Corporation
• 12. Futerro Group
• 13. Galatea Surgical, Inc.
• 14. Huizhou Foryou Medical Devices Co., Ltd.
• 15. Koninklijke DSM N.V.
• 16. MAST Biosurgery
• 17. Merck KGaA
• 18. Mitsui & Co., Ltd.
• 19. Nanosoft Polymers
• 20. Nomisma Healthcare Pvt. Ltd.
• 21. Otto Chemie Pvt. Ltd.
• 22. Poly-Med Incorporated
• 23. PolyNovo Limited
• 24. Polysciences, Inc.
• 25. Putnam Plastics
• 26. REVA Medical, LLC
• 27. Rivika Bio Industries Pvt. Ltd.
• 28. SEQENS SAS
• 29. Solanyl Biopolymers Inc.
• 30. SpecialChem S.A.
• 31. Stahl Holdings B.V.
• 32. Torise Biomaterials Co.,Ltd.
• 33. UBQ Materials Ltd.
• 34. Vibha Ecopac Pvt Ltd.
• 35. Zeus Industrial Products, Inc.